Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“Importantly, treatment with ER β agonist DPN (5 nM) significantly decreased the inhibitory effect of a PTEN knockdown on tamoxifen response of both cell lines (p<0.05).”
“Surprisingly, tamoxifen , an estrogen receptor antagonist used for breast cancer treatment, increased the activity and decreased the Km for NAD+ by about twofold in ALDH1A1.”